Orange Book product · Brand (NDA)
ACUVAIL
KETOROLAC TROMETHAMINE
At a glance
Jul 22, 2009
Approved
Brand (NDA)
Application
Not listed
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 22, 2009
17 yr 2 mo ago
Today
Patent 8512717 expires
Listed drug product patent expiration.
Mar 07, 2028
in 1 yr 9 mo
Patent 9192571 expires
Listed drug product patent expiration.
Mar 07, 2028
in 1 yr 9 mo
Patent 7842714 expires
Listed drug substance patent expiration.
Aug 15, 2029
in 3 yr 2 mo
Pharmaceutical detail
Active ingredient
KETOROLAC TROMETHAMINE
Strength
0.45%
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
Not listed
Application
NDA 022427
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2010SPRIXBrand (NDA)
NDA 022382 · ZYLA
- 2003ACULAR LSBrand (NDA)
NDA 021528 · ABBVIE
- 1997ACULAR PRESERVATIVE FREEBrand (NDA)
NDA 020811 · ALLERGAN
- 1992ACULARBrand (NDA)
NDA 019700 · ABBVIE
- 1989TORADOLBrand (NDA)
NDA 019698 · ROCHE PALO
- 2024KETOROLAC TROMETHAMINEGeneric (ANDA)
ANDA 218204 · CAPLIN
- 2023KETOROLAC TROMETHAMINEGeneric (ANDA)
ANDA 217166 · ASPIRO
- 2023KETOROLAC TROMETHAMINEGeneric (ANDA)
ANDA 217789 · CAPLIN
- 2023KETOROLAC TROMETHAMINEGeneric (ANDA)
ANDA 216759 · BIONPHARMA
- 2022KETOROLAC TROMETHAMINEGeneric (ANDA)
ANDA 214456 · ALEMBIC
- 2022KETOROLAC TROMETHAMINEGeneric (ANDA)
ANDA 216407 · ATNAHS PHARMA US
- 2020KETOROLAC TROMETHAMINEGeneric (ANDA)
ANDA 205190 · EUGIA PHARMA
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8512717 | Mar 07, 2028 | in 1 yr 9 mo | Product |
| 9192571 | Mar 07, 2028 | in 1 yr 9 mo | Product |
| 7842714 | Aug 15, 2029 | in 3 yr 2 mo | SubstanceProduct |

